| |  |
| |
| | A schematic representation of the domain structure and the three-dimensional structure of GBP-1. GBP-1 consists of a globular domain (residues 1 to 278), which contains the GTP binding and hydrolysis domains, and of a helical domain (residues 279 to 593) terminated by a polybasic sequence and an isoprenylation motif (CAAX). C= Cysteine, A= aliphatic acid, X= any amino-acid (here a serine, specifically recognized by a farnesyl-transferase). |
| |
| Description | GBP-1 belongs to the class of large GTPases that contains, in addition to the GBPs, three further groups of proteins, which share structural and biochemical properties: the dynamins, the Mx proteins and the atlastins. GBP-1 has a molecular weight of 67 kDa and its crystal structure has revealed the presence of two domains: (1) a N-terminal globular alpha/beta domain harbouring the GTPase activity and (2) a long C-terminal part organized in an index finger-like domain composed exclusively of seven alpha-helices (alpha7 - alpha13). The domains are connected by a short intermediate region consisting of one alpha-helix and a short two-stranded beta-sheet. In addition, GBP-1 harbours a C-terminal CAAX isoprenylation motif. GTPases typically harbour three classical GTP-binding domains: the phosphate-binding P-loop GXXXXGK(S/T), the phosphate- and Mg2+-binding DXXG motif (G, glycine; K, lysine; S, serine; D, aspartic acid; T, threonine; and X, any amino acid) and the guanine nucleotide-specificity providing (N/T)KXD motif (N, asparagine). In GBP-1 the classical (N/T)KXD motif is substituted by a conserved arginine-aspartic acid (RD)-motif (TLRD, with L, leucine and R, arginine). |
| Expression | GBP-1 was initially shown to be among the most highly induced proteins in human fibroblasts exposed to interferon (IFN)-gamma. Subsequently, it was reported that in vitro hGBP-1 expression can be induced by IFN-gamma in many different cell types including endothelial cells, fibroblasts, keratinocytes, B-cells, T-cells or peripheral blood mononuclear cells. In vivo expression of hGBP-1 has been predominantly detected in inflammatory tissues and has been found to be associated almost exclusively with endothelial cells and monocytes. It has been shown subsequently that hGBP-1 expression in endothelial cells is also induced by other pro-inflammatory cytokines such as IFNalpha, TNFalpha and IL1alpha/IL1beta. Many other cytokines (IL-4, IL-6, IL-10, IL-18), chemokines (MCP-1, PF4) or growth factors (angiopoietin-2, PDGF B/B) tested did not affect GBP-1 expression in these cells. Interestingly, the two major angiogenic growth factors (AGF: bFGF, VEGF) are able to inhibit the expression of GBP-1 induced by inflammatory cytokines. |
| Localisation | The localization of GBP-1 is primarily cytosolic and its distribution is granular. Plasma membrane association at the level of tight junctions has also been described. In addition, GBP-1 has been shown to be secreted from IFN-gamma-stimulated endothelial cells through a non-classical secretion pathway. |
| Function | GTPase activity GBP-1 can bind the three nucleotides GTP, GDP and GMP with a relative low affinity (Kd mant-GMP=0,53 μM, Kd mant-GDP=2,4 μM, Kdmant-GppNHp=1,1 μM). GBP-1 has however the ability to hydrolyse GTP to both GDP and GMP with a high hydrolysis rate (max 95 min-1). At physiological temperature GMP is the major product (90%) of hGBP1. On the contrary to small GTPases like Ras, GBP-1 does not require the presence of GEF (GTP exchange factor) or GAP (GTPase activating protein) proteins for its GTPase activity. In the case of GBP-1, the GTP hydrolysis is self-stimulated by oligomerization of the protein. GBP-1 is involved in IFN-gamma response, either in infection or in inflammation. |
| Homology | The human GBP family comprises 7 highly homologous members, all located on the chromosome 1. GBP-1 is to 77% similar to GBP-2, 88% to GBP-3, 56% to GBP-4, 68% to GBP-5, 54% to GBP-6 and 56% to GBP-7. Homologues have been found in various species like zebrafish, chimpanzee (99% homology), rat, dog or mouse. GBP-1 shares 59% of homology with murine GBP-1 and murine GBP-2. |
| Interferon induction of fibroblast proteins with guanylate binding activity. |
| Cheng YS, Colonno RJ, Yin FH. |
| J Biol Chem. 1983 Jun 25;258(12):7746-50. |
| PMID 6305951 |
| |
| Affinity purification of an interferon-induced human guanylate-binding protein and its characterization. |
| Cheng YS, Becker-Manley MF, Chow TP, Horan DC. |
| J Biol Chem. 1985 Dec 15;260(29):15834-9. |
| PMID 3934165 |
| |
| The interferon-induced 67-kDa guanylate-binding protein (hGBP1) is a GTPase that converts GTP to GMP. |
| Schwemmle M, Staeheli P. |
| J Biol Chem. 1994 Apr 15;269(15):11299-305. |
| PMID 7512561 |
| |
| Prenylation of an interferon-gamma-induced GTP-binding protein: the human guanylate binding protein, huGBP1. |
| Nantais DE, Schwemmle M, Stickney JT, Vestal DJ, Buss JE. |
| J Leukoc Biol. 1996 Sep;60(3):423-31. |
| PMID 8830800 |
| |
| Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. |
| Anderson SL, Carton JM, Lou J, Xing L, Rubin BY. |
| Virology. 1999 Mar 30;256(1):8-14. |
| PMID 10087221 |
| |
| Nucleotide-binding characteristics of human guanylate-binding protein 1 (hGBP1) and identification of the third GTP-binding motif. |
| Praefcke GJ, Geyer M, Schwemmle M, Robert Kalbitzer H, Herrmann C. |
| J Mol Biol. 1999 Sep 17;292(2):321-32. |
| PMID 10493878 |
| |
| Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. |
| Prakash B, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C. |
| Nature. 2000 Feb 3;403(6769):567-71. |
| PMID 10676968 |
| |
| Triphosphate structure of guanylate-binding protein 1 and implications for nucleotide binding and GTPase mechanism. |
| Prakash B, Renault L, Praefcke GJ, Herrmann C, Wittinghofer A. |
| EMBO J. 2000 Sep 1;19(17):4555-64. |
| PMID 10970849 |
| |
| The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. |
| Guenzi E, Topolt K, Cornali E, Lubeseder-Martellato C, Jorg A, Matzen K, Zietz C, Kremmer E, Nappi F, Schwemmle M, Hohenadl C, Barillari G, Tschachler E, Monini P, Ensoli B, Sturzl M. |
| EMBO J. 2001 Oct 15;20(20):5568-77. |
| PMID 11598000 |
| |
| Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. |
| Lubeseder-Martellato C, Guenzi E, Jorg A, Topolt K, Naschberger E, Kremmer E, Zietz C, Tschachler E, Hutzler P, Schwemmle M, Matzen K, Grimm T, Ensoli B, Sturzl M. |
| Am J Pathol. 2002 Nov;161(5):1749-59. |
| PMID 12414522 |
| |
| The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. |
| Guenzi E, Topolt K, Lubeseder-Martellato C, Jorg A, Naschberger E, Benelli R, Albini A, Sturzl M. |
| EMBO J. 2003 Aug 1;22(15):3772-82. |
| PMID 12881412 |
| |
| Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. |
| Naschberger E, Werner T, Vicente AB, Guenzi E, Topolt K, Leubert R, Lubeseder-Martellato C, Nelson PJ, Sturzl M. |
| Biochem J. 2004 Apr 15;379(Pt 2):409-20. |
| PMID 14741045 |
| |
| Identification of residues in the human guanylate-binding protein 1 critical for nucleotide binding and cooperative GTP hydrolysis. |
| Praefcke GJ, Kloep S, Benscheid U, Lilie H, Prakash B, Herrmann C. |
| J Mol Biol. 2004 Nov 12;344(1):257-69. |
| PMID 15504415 |
| |
| Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactor. |
| Modiano N, Lu YE, Cresswell P. |
| Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8680-5. Epub 2005 Jun 3. |
| PMID 15937107 |
| |
| The guanylate-binding proteins (GBPs): proinflammatory cytokine-induced members of the dynamin superfamily with unique GTPase activity. |
| Vestal DJ. |
| J Interferon Cytokine Res. 2005 Aug;25(8):435-43. (REVIEW) |
| PMID 16108726 |
| |
| How guanylate-binding proteins achieve assembly-stimulated processive cleavage of GTP to GMP. |
| Ghosh A, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C. |
| Nature. 2006 Mar 2;440(7080):101-4. |
| PMID 16511497 |
| |
| Human guanylate binding protein-1 is a secreted GTPase present in increased concentrations in the cerebrospinal fluid of patients with bacterial meningitis. |
| Naschberger E, Lubeseder-Martellato C, Meyer N, Gessner R, Kremmer E, Gessner A, Sturzl M. |
| Am J Pathol. 2006 Sep;169(3):1088-99. |
| PMID 16936281 |
| |
| In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. |
| Olszewski MA, Gray J, Vestal DJ. |
| J Interferon Cytokine Res. 2006 May;26(5):328-52. |
| PMID 16689661 |
| |
| Interferon-alpha prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation. |
| Pammer J, Reinisch C, Birner P, Pogoda K, Sturzl M, Tschachler E. |
| Lab Invest. 2006 Oct;86(10):997-1007. Epub 2006 Aug 7. |
| PMID 16894355 |
| |
| Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. |
| Degrandi D, Konermann C, Beuter-Gunia C, Kresse A, Wurthner J, Kurig S, Beer S, Pfeffer K. |
| J Immunol. 2007 Dec 1;179(11):7729-40. |
| PMID 18025219 |
| |
| Unique features of different members of the human guanylate-binding protein family. |
| Tripal P, Bauer M, Naschberger E, Mortinger T, Hohenadl C, Cornali E, Thurau M, Sturzl M. |
| J Interferon Cytokine Res. 2007 Jan;27(1):44-52. |
| PMID 17266443 |
| |
| Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection. |
| Ito Y, Shibata-Watanabe Y, Ushijima Y, Kawada J, Nishiyama Y, Kojima S, Kimura H. |
| J Infect Dis. 2008 Mar 1;197(5):663-6. |
| PMID 18260761 |
| |
| Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy. |
| Naschberger E, Croner RS, Merkel S, Dimmler A, Tripal P, Amann KU, Kremmer E, Brueckl WM, Papadopoulos T, Hohenadl C, Hohenberger W, Sturzl M. |
| Int J Cancer. 2008 Nov 1;123(9):2120-9. |
| PMID 18697200 |
| |
| Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin alpha4 expression. |
| Weinlander K, Naschberger E, Lehmann MH, Tripal P, Paster W, Stockinger H, Hohenadl C, Sturzl M. |
| FASEB J. 2008 Dec;22(12):4168-78. Epub 2008 Aug 12. |
| PMID 18697840 |
| |
| Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis. |
| Schnoor M, Betanzos A, Weber DA, Parkos CA. |
| Mucosal Immunol. 2009 Jan;2(1):33-42. Epub 2008 Sep 17. |
| PMID 19079332 |
| |
| Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma. |
| Tietzel I, El-Haibi C, Carabeo RA. |
| PLoS One. 2009 Aug 4;4(8):e6499. |
| PMID 19652711 |
| |